RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Opioid Peptide Receptor Studies. 6. The Methylfentanyl Congener RTI-46144 and Its Enantiomers Differ in Efficacy, Potency, and Intrinsic Efficacy as Measured by Stimulation of [35S]GTP-gamma-S Binding Using Cloned mu-Opioid Receptors
Xu, H., Lu, Y.-F., Partilla, JS., Brine, G., Carroll, F., Rice, KC., Lai, J., Porreca, F., & Rothman, RB. (1997). Opioid Peptide Receptor Studies. 6. The Methylfentanyl Congener RTI-46144 and Its Enantiomers Differ in Efficacy, Potency, and Intrinsic Efficacy as Measured by Stimulation of [35S]GTP-gamma-S Binding Using Cloned mu-Opioid Receptors. Analgesia, 3, 35.